These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome. Griese M, Dietrich P, Reinhardt D. Am J Respir Crit Care Med; 1995 Sep; 152(3):1050-4. PubMed ID: 7663782 [Abstract] [Full Text] [Related]
45. The role of amniotic fluid phospholipids in determining fetal lung maturity. Pappas AA, Mullins RE, Gadsden RH. Ann Clin Lab Sci; 1982 Sep; 12(4):304-7. PubMed ID: 6897158 [Abstract] [Full Text] [Related]
46. Surfactant Components and Tracheal Aspirate Inflammatory Markers in Preterm Infants with Respiratory Distress Syndrome. Verlato G, Simonato M, Giambelluca S, Fantinato M, Correani A, Cavicchiolo ME, Priante E, Carnielli V, Cogo P. J Pediatr; 2018 Dec; 203():442-446. PubMed ID: 30270169 [Abstract] [Full Text] [Related]
47. Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: indices of lung maturity. Hallman M, Kulovich M, Kirkpatrick E, Sugarman RG, Gluck L. Am J Obstet Gynecol; 1976 Jul 01; 125(5):613-7. PubMed ID: 180804 [Abstract] [Full Text] [Related]
49. Isolation of the acidic phospholipid phosphatidylglycerol from pulmonary surfactant by sorbent extraction chromatography. Egberts J, Bulskool R. Clin Chem; 1988 Jan 01; 34(1):163-4. PubMed ID: 3123094 [Abstract] [Full Text] [Related]
50. Developmental study of a lamellar body fraction isolated from human amniotic fluid. Oulton M, Martin TR, Faulkner GT, Stinson D, Johnson JP. Pediatr Res; 1980 May 01; 14(5):722-8. PubMed ID: 6892955 [Abstract] [Full Text] [Related]
51. [Superoxide dismutase and catalase activity in tracheobronchial secretions after surfactant treatment of newborn infants with respiratory distress syndrome]. Schröder A, Herting E, Speer CP. Z Geburtshilfe Neonatol; 1999 May 01; 203(5):201-6. PubMed ID: 10596413 [Abstract] [Full Text] [Related]
54. The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome. Cochrane CG, Revak SD, Merritt TA, Heldt GP, Hallman M, Cunningham MD, Easa D, Pramanik A, Edwards DK, Alberts MS. Am J Respir Crit Care Med; 1996 Jan 01; 153(1):404-10. PubMed ID: 8542150 [Abstract] [Full Text] [Related]
55. Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy. Chida S, Phelps DS, Cordle C, Soll R, Floros J, Taeusch HW. Am Rev Respir Dis; 1988 Apr 01; 137(4):943-7. PubMed ID: 3355003 [Abstract] [Full Text] [Related]
56. Perinatal factors influencing the arterial oxygen tension in preterm infants with RDS while breathing 100 per cent oxygen. Thibeault DW, Hobel CJ, Kwong MS. J Pediatr; 1974 Jun 01; 84(6):898-902. PubMed ID: 4406462 [No Abstract] [Full Text] [Related]
57. Surfactant proteins in the diagnosis of fetal lung maturity. I. Predictive accuracy of the 35 kD protein, the lecithin/sphingomyelin ratio, and phosphatidylglycerol. Hallman M, Arjomaa P, Mizumoto M, Akino T. Am J Obstet Gynecol; 1988 Mar 01; 158(3 Pt 1):531-5. PubMed ID: 3348313 [Abstract] [Full Text] [Related]